Q1 2024 Revenue and Business Update
April 17, 2024 03:05 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, April 17, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today provides an update on its revenue and operational performance for the...
TLX101-CDx (Pixclara™) Granted FDA Fast Track Designation
April 15, 2024 18:27 ET
|
Telix Pharmaceuticals Limited
FDA Fast Track designation granted for TLX101-CDx for glioma (brain cancer) imagingCollaboration agreement announced for joint development and commercialisation with UCSF PharmaLogic announced as...
World First Use of Lightpoint's SENSEI® Drop-In Gamma Probe in Bladder Cancer Surgery Performed in Spain
March 26, 2024 17:51 ET
|
Telix Pharmaceuticals Limited; Lightpoint Surgical Limited
LONDON, March 27, 2024 (GLOBE NEWSWIRE) -- Lightpoint Surgical Limited (Lightpoint), an affiliate of Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces a world-first...
QDOSE® Platform Partnership for Personalized Dosimetry in Radiopharmaceutical Therapy
March 18, 2024 17:08 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and DRESDEN, Germany, March 19, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has entered into an agreement to...
Appointment of Dr Darren Patti to Group Chief Operating Officer
March 11, 2024 17:31 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, March 12, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) is pleased to announce the appointment of Dr. Darren Patti as Group Chief...
Telix to Acquire ARTMS, Inc. and its Advanced Isotope Production Platform
March 04, 2024 17:42 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, March 05, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has entered into an agreement to acquire radioisotope...
Telix Expands U.S. Development and Manufacturing Infrastructure with Acquisition of IsoTherapeutics
February 26, 2024 16:27 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has entered into an agreement to acquire IsoTherapeutics...
Telix 2023 Full Year Results: Inaugural Profit Achieved, Strong Revenue Growth Underpins Investment in Late-stage Pipeline
February 22, 2024 03:51 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces its results for the financial year ended 31 December 2023. All...
Telix Signs Agreement to Acquire QSAM Biosciences and Its Bone Cancer Targeting Platform
February 07, 2024 16:43 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has entered into an agreement to acquire QSAM Biosciences,...
Telix Highlights Presentations at Upcoming ASCO Genitourinary Cancers Symposium (ASCO GU 2024)
January 22, 2024 06:00 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces presentations featuring the Company’s theranostic programs at the...